Closed Systems Transfer Devices Market by Closing Mechanism (Color-to-Color Systems), Type (Needleless Systems), Component (Female Components, Male Luers), Technology (Air Cleaning/Filtration Devices), End User (Hospitals & Clinics) - Global Forecast to 2030

1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 STUDY SCOPE 29 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 29 1.3.2 INCLUSIONS AND EXCLUSIONS 30 1.3.3 YEARS CONSIDERED 31 1.4 CURRENCY CONSIDERED 31 1.5 STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 32 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 2.1.1 SECONDARY DATA 34 2.1.1.1 Key data from secondary sources 34 2.1.2 PRIMARY DATA 35 2.1.2.1 Key data from primary sources 36 2.1.2.2 Key industry insights 37 2.2 MARKET SIZE ESTIMATION 39 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 45 2.4 MARKET SHARE ESTIMATION 46 2.5 RESEARCH ASSUMPTIONS 46 2.6 RESEARCH LIMITATIONS 47 2.6.1 SCOPE-RELATED LIMITATIONS 47 2.6.2 METHODOLOGY-RELATED LIMITATIONS 47 2.7 RISK ASSESSMENT 47 3 EXECUTIVE SUMMARY 48 4 PREMIUM INSIGHTS 53 4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW 53 4.2 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY AND COUNTRY, 2024 54 4.3 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGIONAL MIX 55 4.4 CLOSED SYSTEM TRANSFER DEVICES MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 55 4.5 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56   5 MARKET OVERVIEW 57 5.1 INTRODUCTION 57 5.2 MARKET DYNAMICS 57 5.2.1 DRIVERS 58 5.2.1.1 Growing incidence of cancer and subsequent use of chemotherapy 58 5.2.1.2 Increasing regulatory approvals for oncology therapeutics 58 5.2.1.3 Rising awareness about risks associated with handling antineoplastic drugs 59 5.2.1.4 Stringent regulatory guidelines for handling hazardous medication 60 5.2.2 RESTRAINTS 61 5.2.2.1 High implementation costs and limited reimbursements 61 5.2.2.2 Inconsistent regulatory compliance 61 5.2.3 OPPORTUNITIES 62 5.2.3.1 Growth potential across therapeutic applications 62 5.2.3.2 Rising healthcare expenditure in emerging economies 63 5.2.4 CHALLENGES 63 5.2.4.1 Impact of closed system transfer devices on drug quality 63 5.2.4.2 Low awareness and poor implementation of protective measures 64 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 66 5.4 PRICING ANALYSIS 67 5.4.1 AVERAGE SELLING PRICE TREND, BY COMPONENT 67 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 68 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 68 5.5 VALUE CHAIN ANALYSIS 69 5.5.1 RESEARCH & PRODUCT DEVELOPMENT 70 5.5.2 MATERIAL COMPONENT PROCUREMENT AND MANUFACTURING 70 5.5.3 MARKETING & SALES, SHIPMENT, AND AFTERSALES SERVICES 70 5.6 SUPPLY CHAIN ANALYSIS 71 5.7 ECOSYSTEM ANALYSIS 72 5.8 INVESTMENT AND FUNDING SCENARIO 74 5.9 TECHNOLOGY ANALYSIS 75 5.9.1 KEY TECHNOLOGIES 75 5.9.1.1 Needle-free systems 75 5.9.2 COMPLEMENTARY TECHNOLOGIES 76 5.9.2.1 Integration of sensors 76 5.9.3 ADJACENT TECHNOLOGIES 76 5.9.3.1 Advancements in containments 76 5.10 INDUSTRY TRENDS 77 5.10.1 INTEGRATION OF FILTERS IN CLOSED SYSTEM TRANSFER DEVICES 77 5.10.2 AUTOMATION OF TRANSFER PROCESSES 77 5.10.3 ADVANCED MATERIALS FOR DURABILITY AND COMPATIBILITY WITH COMPLEX DRUG FORMULATIONS 78 5.11 PATENT ANALYSIS 79 5.12 TRADE DATA ANALYSIS 81 5.12.1 IMPORT DATA 81 5.12.2 EXPORT DATA 83 5.13 KEY CONFERENCES AND EVENTS, 2025–2026 85 5.14 CASE STUDY ANALYSIS 86 5.14.1 CASE STUDY 1: EXTENSION OF BEYOND-USE DATE OF SINGLE-DOSE VIALS AT MOUNT SINAI HOSPITAL 86 5.14.2 CASE STUDY 2: ENHANCED SAFETY AND EFFICIENCY OF DRUG COMPOUNDING AT NEBRASKA METHODIST HOSPITAL 86 5.14.3 CASE STUDY 3: PREVENTION OF MICROBIAL CONTAMINATION DURING SIMULATED WORST-CASE SCENARIOS 86 5.15 REGULATORY LANDSCAPE 87 5.15.1 REGULATORY STANDARDS AND APPROVALS 87 5.15.1.1 US 87 5.15.1.1.1 USP <800> Regulations 87 5.15.1.1.2 National Institute for Occupational Safety and Health 87 5.15.1.1.3 American Society of Health-System Pharmacists 89 5.15.1.1.4 International Society of Oncology Pharmacy Practitioners 90 5.15.1.2 European Union 90 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 5.16 PORTER’S FIVE FORCES ANALYSIS 94 5.16.1 BARGAINING POWER OF SUPPLIERS 95 5.16.2 BARGAINING POWER OF BUYERS 95 5.16.3 THREAT OF NEW ENTRANTS 95 5.16.4 THREAT OF SUBSTITUTES 96 5.16.5 INTENSITY OF COMPETITIVE RIVALRY 96 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 97 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 97 5.17.2 BUYING CRITERIA 98 5.18 UNMET NEEDS/END-USER EXPECTATIONS 98 5.19 IMPACT OF GEN AI ON CLOSED SYSTEM TRANSFER DEVICES MARKET 99 5.19.1 INTRODUCTION 99 5.19.2 MARKET POTENTIAL OF AI IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET 99 5.19.3 AI USE CASES 100 5.19.4 KEY COMPANIES IMPLEMENTING AI 100 5.19.5 FUTURE OF GENERATIVE AI IN CLOSED SYSTEM TRANSFER DEVICES MARKET 101 5.20 IMPACT OF US TARIFF REGULATION ON CLOSED SYSTEM TRANSFER DEVICES MARKET 101 5.20.1 NORTH AMERICA 101 5.20.2 EUROPE 101 5.20.3 ASIA PACIFIC 102 5.20.4 LATIN AMERICA 102 5.20.5 MIDDLE EAST & AFRICA 102 6 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM 103 6.1 INTRODUCTION 104 6.2 LUER LOCK SYSTEMS 106 6.2.1 GROWING PREVALENCE OF INJECTABLE DRUGS TO PROPEL MARKET 106 6.3 PUSH-TO-TURN SYSTEMS 107 6.3.1 INCREASING FOCUS ON COMPLYING WITH REGULATIONS AND GUIDELINES FOR SAFE HANDLING OF DRUGS TO AID GROWTH 107 6.4 CLICK-TO-LOCK SYSTEMS 109 6.4.1 LOW IMPLEMENTATION COST TO CONTRIBUTE TO GROWTH 109 6.5 COLOR-TO-COLOR ALIGNMENT SYSTEMS 110 6.5.1 GROWING FOCUS ON CURBING RISK OF MEDICATION ERRORS TO FUEL MARKET 110 7 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE 112 7.1 INTRODUCTION 113 7.2 MEMBRANE-TO-MEMBRANE SYSTEMS 114 7.2.1 INCREASING FOCUS ON SAFEGUARDING HEALTH AND WELL-BEING OF HEALTHCARE PROVIDERS TO EXPEDITE GROWTH 114 7.3 NEEDLELESS SYSTEMS 116 7.3.1 EVOLVING MEDICAL DEVICE TECHNOLOGY LANDSCAPE TO STIMULATE GROWTH 116 8 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT 118 8.1 INTRODUCTION 119 8.2 VIAL ACCESS COMPONENTS 120 8.2.1 GROWING CONCERNS SURROUNDING HEALTHCARE-ASSOCIATED INFECTIONS TO DRIVE MARKET 120 8.3 MALE LUERS 123 8.3.1 NEED TO PREVENT AIR EMBOLISM AND PRESERVE INTEGRITY OF INTRAVENOUS SYSTEMS TO PROMOTE GROWTH 123 8.4 BAG SPIKES 125 8.4.1 GROWING FOCUS ON ENHANCED SAFETY, EFFICIENCY, AND PRECISION IN HANDLING AND ADMINISTRATING HAZARDOUS DRUGS TO BOOST MARKET 125 8.5 FEMALE COMPONENTS 127 8.5.1 NEED TO PREVENT CONTAMINATION OF DRUGS AND EQUIPMENT TO ENCOURAGE GROWTH 127 8.6 OTHER COMPONENTS 130   9 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY 132 9.1 INTRODUCTION 133 9.2 DIAPHRAGM-BASED DEVICES 134 9.2.1 INCREASING USE OF DIAPHRAGM-BASED DEVICES IN CHEMOTHERAPY AND OTHER ONCOLOGY TREATMENTS TO FOSTER GROWTH 134 9.3 COMPARTMENTALIZED DEVICES 136 9.3.1 NEED TO MAINTAIN INTEGRITY OF MEDICATIONS DURING TRANSFER TO SUSTAIN GROWTH 136 9.4 AIR CLEANING/FILTRATION DEVICES 138 9.4.1 NEED FOR CLEAN AND STERILE ENVIRONMENT WITHIN PHARMACEUTICAL AND HEALTHCARE FACILITIES TO FACILITATE GROWTH 138 10 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER 140 10.1 INTRODUCTION 141 10.2 HOSPITALS & CLINICS 141 10.2.1 GROWING FOCUS ON ENHANCED STAFF AND PATIENT SAFETY IN HEALTHCARE SETTINGS TO BOOST MARKET 141 10.3 ONCOLOGY CENTERS 142 10.3.1 NEED TO MINIMIZE RISK OF OCCUPATIONAL EXPOSURE TO AUGMENT GROWTH 142 10.4 OTHER END USERS 144 11 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION 146 11.1 INTRODUCTION 147 11.2 NORTH AMERICA 148 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148 11.2.2 US 152 11.2.2.1 Rising focus on best practice recommendations and mandates for healthcare workers to aid growth 152 11.2.3 CANADA 154 11.2.3.1 Increasing demand for antineoplastic drugs to assist growth 154 11.3 EUROPE 157 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 157 11.3.2 GERMANY 160 11.3.2.1 Growing emphasis on healthcare protocols to propel market 160 11.3.3 UK 162 11.3.3.1 Strict guidelines for handling hazardous drugs to promote growth 162 11.3.4 FRANCE 165 11.3.4.1 High healthcare expenditure to accelerate growth 165 11.3.5 SPAIN 167 11.3.5.1 Increasing incidence of cancer to favor growth 167   11.3.6 ITALY 169 11.3.6.1 Rising geriatric population and subsequent prevalence of chronic diseases to aid growth 169 11.3.7 REST OF EUROPE 172 11.4 ASIA PACIFIC 174 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 174 11.4.2 JAPAN 178 11.4.2.1 Established healthcare system and rising geriatric population to drive market 178 11.4.3 CHINA 180 11.4.3.1 Large target patient population to stimulate growth 180 11.4.4 INDIA 183 11.4.4.1 Rising adoption of chemotherapy procedures to facilitate growth 183 11.4.5 AUSTRALIA AND NEW ZEALAND 185 11.4.5.1 Rising incidence of chronic diseases to speed up growth 185 11.4.6 SOUTH KOREA 187 11.4.6.1 Shift to aging demography to spur growth 187 11.4.7 REST OF ASIA PACIFIC 190 11.5 LATIN AMERICA 192 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 192 11.5.2 BRAZIL 194 11.5.2.1 Booming healthcare and pharmaceutical sectors to amplify growth 194 11.5.3 MEXICO 197 11.5.3.1 Rising initiatives on universal healthcare coverage to support growth 197 11.5.4 COLOMBIA 199 11.5.4.1 Growing prioritization of patient and worker safety to bolster growth 199 11.5.5 REST OF LATIN AMERICA 201 11.6 MIDDLE EAST & AFRICA 204 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 204 11.6.2 GCC COUNTRIES 206 11.6.2.1 Higher disposable incomes to expedite growth 206 11.6.3 REST OF MIDDLE EAST & AFRICA 209 12 COMPETITIVE LANDSCAPE 212 12.1 OVERVIEW 212 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 212 12.3 REVENUE ANALYSIS, 2020–2024 215 12.4 MARKET SHARE ANALYSIS, 2024 216 12.5 R&D ASSESSMENT OF KEY PLAYERS 217 12.6 COMPANY VALUATION AND FINANCIAL METRICES 218   12.7 BRAND/PRODUCT COMPARISON 219 12.7.1.1 BD 220 12.7.1.2 ICU Medical, Inc. 220 12.7.1.3 B. Braun Melsungen AG 220 12.7.1.4 JMS Co. Ltd. 220 12.7.1.5 Baxter 220 12.7.1.6 EQUASHIELD 220 12.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 221 12.8.1 STARS 221 12.8.2 EMERGING LEADERS 221 12.8.3 PERVASIVE PLAYERS 221 12.8.4 PARTICIPANTS 221 12.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 223 12.8.5.1 Company footprint 223 12.8.5.2 Region footprint 224 12.8.5.3 Closing mechanism footprint 225 12.8.5.4 Type footprint 226 12.8.5.5 Component footprint 227 12.8.5.6 Technology footprint 228 12.8.5.7 End-user footprint 229 12.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 230 12.9.1 PROGRESSIVE COMPANIES 230 12.9.2 RESPONSIVE COMPANIES 230 12.9.3 DYNAMIC COMPANIES 230 12.9.4 STARTING BLOCKS 230 12.9.5 COMPETITIVE BENCHMARKING 232 12.9.5.1 Detailed list of key startups/SMEs 232 12.9.5.2 Competitive benchmarking of key startups/SMEs 233 12.10 COMPETITIVE SCENARIO 233 12.10.1 PRODUCT LAUNCHES AND APPROVALS 233 12.10.2 DEALS 234 12.10.3 EXPANSIONS 235 13 COMPANY PROFILES 236 13.1 KEY PLAYERS 236 13.1.1 BD 236 13.1.1.1 Business overview 236 13.1.1.2 Products offered 237 13.1.1.3 Recent developments 238 13.1.1.3.1 Deals 238 13.1.1.4 MnM view 239 13.1.1.4.1 Right to win 239 13.1.1.4.2 Strategic choices 239 13.1.1.4.3 Weaknesses and competitive threats 239 13.1.2 ICU MEDICAL, INC. 240 13.1.2.1 Business overview 240 13.1.2.2 Products offered 242 13.1.2.3 Recent developments 243 13.1.2.3.1 Deals 243 13.1.2.4 MnM view 243 13.1.2.4.1 Right to win 243 13.1.2.4.2 Strategic choices 243 13.1.2.4.3 Weaknesses and competitive threats 243 13.1.3 B. BRAUN MELSUNGEN AG 244 13.1.3.1 Business overview 244 13.1.3.2 Products offered 246 13.1.3.3 Recent developments 246 13.1.3.3.1 Product launches and approvals 246 13.1.3.3.2 Expansions 247 13.1.3.4 MnM view 247 13.1.3.4.1 Right to win 247 13.1.3.4.2 Strategic choices 247 13.1.3.4.3 Weaknesses and competitive threats 247 13.1.4 JMS CO. LTD. 248 13.1.4.1 Business overview 248 13.1.4.2 Products offered 249 13.1.4.3 MnM view 249 13.1.4.3.1 Right to win 249 13.1.4.3.2 Strategic choices 249 13.1.4.3.3 Weaknesses and competitive threats 249 13.1.5 BAXTER 250 13.1.5.1 Business overview 250 13.1.5.2 Products offered 251 13.1.5.3 Recent developments 252 13.1.5.3.1 Deals 252 13.1.5.4 MnM view 252 13.1.5.4.1 Right to win 252 13.1.5.4.2 Strategic choices 252 13.1.5.4.3 Weaknesses and competitive threats 252 13.1.6 WEST PHARMACEUTICAL SERVICES, INC. 253 13.1.6.1 Business overview 253 13.1.6.2 Products offered 255 13.1.6.3 Recent developments 255 13.1.6.3.1 Expansions 255 13.1.7 TERUMO CORPORATION 256 13.1.7.1 Business overview 256 13.1.7.2 Products offered 257 13.1.7.3 Recent developments 258 13.1.7.3.1 Expansions 258 13.1.8 CARDINAL HEALTH 259 13.1.8.1 Business overview 259 13.1.8.2 Products offered 260 13.1.9 EQUASHIELD 261 13.1.9.1 Business overview 261 13.1.9.2 Products offered 261 13.1.9.3 Recent developments 262 13.1.9.3.1 Product launches and approvals 262 13.1.9.3.2 Deals 262 13.1.10 SIMPLIVIA HEALTHCARE LTD. 263 13.1.10.1 Business overview 263 13.1.10.2 Products offered 263 13.1.10.3 Recent developments 264 13.1.10.3.1 Deals 264 13.1.11 YUKON MEDICAL 265 13.1.11.1 Business overview 265 13.1.11.2 Products offered 265 13.1.12 CODAN MEDIZINISCHE GERÄTE GMBH 266 13.1.12.1 Business overview 266 13.1.12.2 Products offered 267 13.1.13 VYGON 268 13.1.13.1 Business overview 268 13.1.13.2 Products offered 268 13.1.13.3 Recent developments 269 13.1.13.3.1 Deals 269 13.1.14 ELCAM MEDICAL 270 13.1.14.1 Business overview 270 13.1.14.2 Products offered 270 13.1.15 PRACTIVET, INC. 271 13.1.15.1 Business overview 271 13.1.15.2 Products offered 271   13.2 OTHER COMPANIES 272 13.2.1 CARAGEN 272 13.2.2 CORVIDA MEDICAL 273 13.2.3 VICTUS 274 13.2.4 EPIC SYSTEMS CORPORATIONS 275 13.2.5 ERASER MEDICAL 276 13.2.6 NEEDLELESS CORPORATION 277 13.2.7 AMSINO INTERNATIONAL, INC. 278 13.2.8 INSUNG MEDICAL CO., LTD. 279 13.2.9 ADVCARE MEDICAL, INC. 280 13.2.10 SHANDONG ANDE HEALTHCARE APPARATUS CO., LTD. 280 14 APPENDIX 281 14.1 DISCUSSION GUIDE 281 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 286 14.3 CUSTOMIZATION OPTIONS 288 14.4 RELATED REPORTS 288 14.5 AUTHOR DETAILS 289

TABLE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET: INCLUSIONS AND EXCLUSIONS 30 TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021–2024 31 TABLE 3 CLOSED SYSTEM TRANSFER DEVICES MARKET: RISK ASSESSMENT ANALYSIS 47 TABLE 4 NATIONAL/LOCAL REGULATORY BODIES RECOMMENDING CLOSED SYSTEM TRANSFER DEVICES FOR MEDICATION HANDLING, BY COUNTRY 60 TABLE 5 CLOSED SYSTEM TRANSFER DEVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 65 TABLE 6 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY COMPONENT, 2022−2024 67 TABLE 7 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY KEY PLAYER, 2022−2024 68 TABLE 8 AVERAGE SELLING TREND OF CLOSED SYSTEM TRANSFER COMPONENTS, BY REGION, 2022−2024 69 TABLE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 73 TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2022−2024 80 TABLE 11 IMPORT DATA FOR HS CODE 901890 BY COUNTRY, 2020–2024 (USD THOUSAND) 82 TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 84 TABLE 13 CLOSED SYSTEM TRANSFER DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 85 TABLE 14 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH: CLASSIFICATION OF HAZARDOUS DRUGS 88 TABLE 15 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH: HAZARDOUS DRUG ADMINISTRATION RECOMMENDATIONS AND <USP 800> REQUIREMENTS 88 TABLE 16 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH AND AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS: DEFINITIONS FOR HAZARDOUS DRUGS 90 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 22 CLOSED SYSTEM TRANSFER DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 94 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TECHNOLOGIES (%) 97 TABLE 24 KEY BUYING CRITERIA FOR TOP THREE TECHNOLOGIES 98 TABLE 25 KEY COMPANIES IMPLEMENTING AI 100 TABLE 26 CLOSING MECHANISMS AVAILABLE IN CLOSED SYSTEM TRANSFER DEVICES 104 TABLE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 105 TABLE 28 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR LUER LOCK SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 29 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR PUSH-TO-TURN SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 30 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR CLICK-TO-LOCK SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 31 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR COLOR-TO-COLOR ALIGNMENT SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 113 TABLE 33 LEADING MANUFACTURERS OF MEMBRANE-TO-MEMBRANE SYSTEMS 114 TABLE 34 MEMBRANE-TO-MEMBRANE CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 35 LEADING MANUFACTURERS OF NEEDLELESS SYSTEMS 116 TABLE 36 NEEDLELESS CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 37 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 119 TABLE 38 VIAL ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 120 TABLE 39 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS COMPONENTS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 40 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS COMPONENTS, BY REGION, 2023–2030 (THOUSAND UNITS) 122 TABLE 41 MALE LUERS FOR CLOSED SYSTEM TRANSFER DEVICES 123 TABLE 42 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR MALE LUERS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 43 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR MALE LUERS, BY REGION, 2023–2030 (THOUSAND UNITS) 124 TABLE 44 BAG SPIKE COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 125 TABLE 45 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG SPIKES, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG SPIKES, BY REGION, 2021–2029 (THOUSAND UNITS) 127 TABLE 47 FEMALE COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 128 TABLE 48 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR FEMALE COMPONENTS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 49 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR FEMALE COMPONENTS, BY REGION, 2023–2030 (THOUSAND UNITS) 129 TABLE 50 OTHER COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 130 TABLE 51 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER COMPONENTS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 52 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 133 TABLE 53 DIAPHRAGM-BASED DEVICES AVAILABLE IN MARKET 134 TABLE 54 DIAPHRAGM-BASED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 55 COMPARTMENTALIZED DEVICES AVAILABLE IN MARKET 136 TABLE 56 COMPARTMENTALIZED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 57 AIR CLEANING/FILTRATION DEVICES AVAILABLE IN MARKET 138 TABLE 58 AIR CLEANING/FILTRATION CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 59 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 141 TABLE 60 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 61 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ONCOLOGY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 62 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 63 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 64 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 65 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 150 TABLE 66 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 67 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 151 TABLE 68 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 151 TABLE 69 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 70 US: KEY MACROECONOMIC INDICATORS 152 TABLE 71 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 153 TABLE 72 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 73 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 153 TABLE 74 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 154 TABLE 75 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 76 CANADA: KEY MACROECONOMIC INDICATORS 155 TABLE 77 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 155 TABLE 78 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 79 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 156 TABLE 80 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 156 TABLE 81 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 82 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 83 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 158 TABLE 84 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 85 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 159 TABLE 86 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 159 TABLE 87 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 88 GERMANY: KEY MACROECONOMIC INDICATORS 160 TABLE 89 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 161 TABLE 90 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 91 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 161 TABLE 92 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 162 TABLE 93 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 94 UK: KEY MACROECONOMIC INDICATORS 163 TABLE 95 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 163 TABLE 96 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 97 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 164 TABLE 98 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 164 TABLE 99 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 100 FRANCE: KEY MACROECONOMIC INDICATORS 165 TABLE 101 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 165 TABLE 102 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 103 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 166 TABLE 104 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 166 TABLE 105 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 106 SPAIN: KEY MACROECONOMIC INDICATORS 167 TABLE 107 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 168 TABLE 108 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 109 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 168 TABLE 110 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 169 TABLE 111 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 112 ITALY: KEY MACROECONOMIC INDICATORS 170 TABLE 113 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 170 TABLE 114 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 115 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 171 TABLE 116 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 171 TABLE 117 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 118 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 172 TABLE 119 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 120 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 173 TABLE 121 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 173 TABLE 122 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 123 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 124 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 176 TABLE 125 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 126 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 177 TABLE 127 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 177 TABLE 128 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 129 JAPAN: KEY MACROECONOMIC INDICATORS 178 TABLE 130 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 179 TABLE 131 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 132 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 179 TABLE 133 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 180 TABLE 134 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 135 CHINA: KEY MACROECONOMIC INDICATORS 181 TABLE 136 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 181 TABLE 137 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 138 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 182 TABLE 139 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 182 TABLE 140 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 141 INDIA: KEY MACROECONOMIC INDICATORS 183 TABLE 142 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 183 TABLE 143 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 144 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 184 TABLE 145 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 184 TABLE 146 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 147 AUSTRALIA: KEY MACROECONOMIC INDICATORS 185 TABLE 148 NEW ZEALAND: KEY MACROECONOMIC INDICATORS 185 TABLE 149 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 186 TABLE 150 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 151 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 186 TABLE 152 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 187 TABLE 153 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 154 SOUTH KOREA: KEY MACROECONOMIC INDICATORS 188 TABLE 155 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 188 TABLE 156 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 157 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 189 TABLE 158 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 189 TABLE 159 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 189 TABLE 160 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 190 TABLE 161 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 162 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 191 TABLE 163 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 191 TABLE 164 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 191 TABLE 165 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 166 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 193 TABLE 167 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 168 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 193 TABLE 169 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 194 TABLE 170 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 194 TABLE 171 BRAZIL: KEY MACROECONOMIC INDICATORS 195 TABLE 172 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 195 TABLE 173 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 174 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 196 TABLE 175 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 196 TABLE 176 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 177 MEXICO: KEY MACROECONOMIC INDICATORS 197 TABLE 178 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 197 TABLE 179 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 180 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 198 TABLE 181 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 198 TABLE 182 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 199 TABLE 183 COLOMBIA: KEY MACROECONOMIC INDICATORS 199 TABLE 184 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 200 TABLE 185 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 186 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 200 TABLE 187 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 201 TABLE 188 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 201 TABLE 189 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 202 TABLE 190 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 191 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 203 TABLE 192 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 203 TABLE 193 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 194 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 204 TABLE 195 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 205 TABLE 196 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 197 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 205 TABLE 198 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 206 TABLE 199 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 200 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 207 TABLE 201 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 202 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 208 TABLE 203 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 208 TABLE 204 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 205 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 209 TABLE 206 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 207 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 210 TABLE 208 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 210 TABLE 209 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 211 TABLE 210 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, JANUARY 2022–MARCH 2025 213 TABLE 211 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEGREE OF COMPETITION 217 TABLE 212 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGION FOOTPRINT 224 TABLE 213 CLOSED SYSTEM TRANSFER DEVICES MARKET: CLOSING MECHANISM FOOTPRINT 225 TABLE 214 CLOSED SYSTEM TRANSFER DEVICES MARKET: TYPE FOOTPRINT 226 TABLE 215 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPONENT FOOTPRINT 227 TABLE 216 CLOSED SYSTEM TRANSFER DEVICES MARKET: TECHNOLOGY FOOTPRINT 228 TABLE 217 CLOSED SYSTEM TRANSFER DEVICES MARKET: END-USER FOOTPRINT 229 TABLE 218 CLOSED SYSTEM TRANSFER DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 232 TABLE 219 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 233 TABLE 220 CLOSED SYSTEM TRANSFER DEVICES MARKET: PRODUCT LAUNCHES A ND APPROVALS, JANUARY 2021−MARCH 2025 234 TABLE 221 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEALS, JANUARY 2021−MARCH 2025 234 TABLE 222 CLOSED SYSTEM TRANSFER DEVICES MARKET: EXPANSIONS, JANUARY 2021−MARCH 2025 235 TABLE 223 BD: COMPANY OVERVIEW 236 TABLE 224 BD: PRODUCTS OFFERED 237 TABLE 225 BD: EXPANSIONS, JANUARY 2021–MARCH 2025 238 TABLE 226 ICU MEDICAL, INC.: COMPANY OVERVIEW 240 TABLE 227 ICU MEDICAL, INC.: PRODUCTS OFFERED 242 TABLE 228 ICU MEDICAL, INC.: DEALS, JANUARY 2021–MARCH 2025 243 TABLE 229 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 244 TABLE 230 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 246 TABLE 231 B. BRAUN MELSUNGEN AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MARCH 2025 246 TABLE 232 B. BRAUN MELSUNGEN AG: EXPANSIONS, JANUARY 2021–MARCH 2025 247 TABLE 233 JMS CO. LTD.: COMPANY OVERVIEW 248 TABLE 234 JMS CO. LTD.: PRODUCTS OFFERED 249 TABLE 235 BAXTER: COMPANY OVERVIEW 250 TABLE 236 BAXTER: PRODUCTS OFFERED 251 TABLE 237 BAXTER: DEALS, JANUARY 2021–MARCH 2025 252 TABLE 238 WEST PHARMACEUTICAL SERVICES, INC: COMPANY OVERVIEW 253 TABLE 239 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED 255 TABLE 240 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS, JANUARY 2021–MARCH 2025 255 TABLE 241 TERUMO CORPORATION: COMPANY OVERVIEW 256 TABLE 242 TERUMO CORPORATION: PRODUCTS OFFERED 257 TABLE 243 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021–MARCH 2024 258 TABLE 244 CARDINAL HEALTH: COMPANY OVERVIEW 259 TABLE 245 CARDINAL HEALTH: PRODUCTS OFFERED 260 TABLE 246 EQUASHIELD: COMPANY OVERVIEW 261 TABLE 247 EQUASHIELD: PRODUCTS OFFERED 261 TABLE 248 EQUASHIELD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MARCH 2025 262 TABLE 249 EQUASHIELD: DEALS, JANUARY 2021–MARCH 2025 262 TABLE 250 SIMPLIVIA HEALTHCARE LTD.: COMPANY OVERVIEW 263 TABLE 251 SIMPLVIA HEALTHCARE LTD.: PRODUCTS OFFERED 263 TABLE 252 SIMPLVIA HEALTHCARE LTD.: DEALS, JANUARY 2021–MARCH 2025 264 TABLE 253 YUKON MEDICAL: COMPANY OVERVIEW 265 TABLE 254 YUKON MEDICAL: PRODUCTS OFFERED 265 TABLE 255 CODAN MEDIZINISCHE GERÄTE GMBH: COMPANY OVERVIEW 266 TABLE 256 CODAN MEDIZINISCHE GERÄTE GMBH: PRODUCTS OFFERED 267   TABLE 257 VYGON: COMPANY OVERVIEW 268 TABLE 258 VYGON: PRODUCTS OFFERED 268 TABLE 259 VYGON: DEALS, JANUARY 2021–MARCH 2025 269 TABLE 260 ELCAM MEDICAL: COMPANY OVERVIEW 270 TABLE 261 ELCAM MEDICAL: PRODUCTS OFFERED 270 TABLE 262 PRACTIVET, INC.: COMPANY OVERVIEW 271 TABLE 263 PRACTIVET, INC.: PRODUCTS OFFERED 271 TABLE 264 CARAGEN: COMPANY OVERVIEW 272 TABLE 265 CORVIDA MEDICAL: COMPANY OVERVIEW 273 TABLE 266 VICTUS: COMPANY OVERVIEW 274 TABLE 267 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 275 TABLE 268 ERASER MEDICAL: COMPANY OVERVIEW 276 TABLE 269 NEEDLELESS CORPORATION: COMPANY OVERVIEW 277 TABLE 270 AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW 278 TABLE 271 INSUNG MEDICAL CO., LTD.: COMPANY OVERVIEW 279 TABLE 272 ADVCARE MEDICAL, INC.: COMPANY OVERVIEW 280 TABLE 273 SHANDONG ANDE HEALTHCARE APPARATUS CO., LTD.: COMPANY OVERVIEW 280 _ _ FIGURE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET SEGMENTATION AND REGIONAL SCOPE 29 FIGURE 2 RESEARCH DESIGN 33 FIGURE 3 PRIMARY SOURCES 35 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 37 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 38 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 38 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 39 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF ICU MEDICAL, INC., 2024 40 FIGURE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION 41 FIGURE 10 CLOSED SYSTEM TRANSFER DEVICES MARKET: BOTTOM-UP APPROACH 41 FIGURE 11 CLOSED SYSTEM TRANSFER DEVICE MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH FOR US MARKET 42 FIGURE 12 CLOSED SYSTEM TRANSFER DEVICES MARKET: TOP-DOWN APPROACH 42 FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2029 44 FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44 FIGURE 15 DATA TRIANGULATION METHODOLOGY 45 FIGURE 16 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2025 VS. 2030 (USD MILLION) 48 FIGURE 17 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 49 FIGURE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2025 VS. 2030 (USD MILLION) 49 FIGURE 19 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 50 FIGURE 20 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 51 FIGURE 21 GEOGRAPHIC SNAPSHOT OF CLOSED SYSTEM TRANSFER DEVICES MARKET 52 FIGURE 22 RISING INCIDENCE OF CANCER AND SUBSEQUENT USE OF CHEMOTHERAPY TO DRIVE MARKET 53 FIGURE 23 DIAPHRAGM-BASED DEVICES SEGMENT AND JAPAN LED ASIA PACIFIC CLOSED SYSTEM TRANSFER DEVICES MARKET IN 2024 54 FIGURE 24 NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 55 FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 55 FIGURE 26 CHINA TO GROW AT HIGHEST GROWTH CAGR DURING FORECAST PERIOD 56 FIGURE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57   FIGURE 28 NEW REVENUE POCKETS FOR PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET 66 FIGURE 29 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY COMPONENT, 2022−2024 67 FIGURE 30 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY KEY PLAYER, 2022–2024 (USD) 68 FIGURE 31 AVERAGE SELLING PRICE OF CLOSED SYSTEM TRANSFER COMPONENTS, BY REGION, 2022–2024 (USD) 69 FIGURE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET: VALUE CHAIN ANALYSIS 70 FIGURE 33 CLOSED SYSTEM TRANSFER DEVICES MARKET: SUPPLY CHAIN ANALYSIS 71 FIGURE 34 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 72 FIGURE 35 INVESTMENT AND FUNDING SCENARIO, 2019–2023 74 FIGURE 36 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 74 FIGURE 37 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 75 FIGURE 38 PATENT ANALYSIS, JANUARY 2015−MARCH 2025 79 FIGURE 39 IMPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 82 FIGURE 40 EXPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 83 FIGURE 41 PORTER’S FIVE FORCES ANALYSIS 94 FIGURE 42 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TECHNOLOGIES 97 FIGURE 43 KEY BUYING CRITERIA FOR TOP THREE TECHNOLOGIES 98 FIGURE 44 AI USE CASES 100 FIGURE 45 CLOSED SYSTEM TRANSFER DEVICE PRICING PER UNIT, BY VENDOR 105 FIGURE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 147 FIGURE 47 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 149 FIGURE 48 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 175 FIGURE 49 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, 2020−2024 215 FIGURE 50 CLOSED SYSTEM TRANSFER DEVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 216 FIGURE 51 R&D EXPENDITURE OF KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, 2022 VS. 2023 217 FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 218 FIGURE 53 EV/EBITDA OF KEY VENDORS 218 FIGURE 54 CLOSED SYSTEM TRANSFER DEVICES MARKET: BRAND/PRODUCT COMPARISON 219 FIGURE 55 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 222 FIGURE 56 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY FOOTPRINT 223 FIGURE 57 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 231 FIGURE 58 BD: COMPANY SNAPSHOT (2024) 237 FIGURE 59 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 241   FIGURE 60 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2023) 245 FIGURE 61 JMS CO. LTD.: COMPANY SNAPSHOT (2024) 248 FIGURE 62 BAXTER: COMPANY SNAPSHOT (2024) 251 FIGURE 63 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2024) 254 FIGURE 64 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 257 FIGURE 65 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 260